The “Pediatric Interventional Cardiology Market by Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018” This report studies the global pediatric interventional cardiology market over the forecast period of 2013 to 2018. This market is valued at an estimated $894.7 million in 2013 and is poised to grow at a CAGR of 9.0% from 2013 to 2018.
Browse more than 90 market data tables with 19 figures spread through 165 pages and in-depth TOC on "Pediatric Interventional Cardiology Market ”
http://www.marketsandmarkets.com/Market-Reports/pediatric-interventional-cardiology-market-236831456.html Early buyers will receive 10% customization on This reports.
Various new procedures and interventional devices are being developed and launched in the market, which is a major reason for the rapid growth of this market. Companies are heavily investing in R&D, to develop new and advanced devices that cater to the unmet needs of pediatric patients. Furthermore, the high growth potential of the transcatheter heart valves market is another factor that is propelling the growth of this market. Based on device type, the ASD, VSD, and PFO devices market accounted for the largest share of 28% in 2013. However, the transcatheter pulmonary valve market is poised to grow at the highest CAGR from 2013 to 2018.
On the basis of product, the interventional cardiology market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. The angioplasty stents segment showcase high growth potential owing to technological advancements, rising number of regulatory approvals, and increasing investments by companies to develop new devices.
On the basis of type, the angioplasty stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. The drug-eluting stents segment is projected to witness the highest growth in this market due to increasing number of regulatory approvals and new product launches.
On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. The IVUS/OCT segment is projected to witness the highest growth in this market due to increasing penetration rates and rapid advancements & innovations in these systems.
On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. The abdominal aortic aneurysms segment is projected to witness the highest growth in this market due to rising incidence of smoking and hypertension.
The Sample Report For This Report@
http://www.marketsandmarkets.com/requestsample.asp?id=548
Geographically, the interventional cardiology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by the rising incidence of cardiovascular diseases, rapidly growing geriatric population, and technological advancements. However, the Asian market is projected to grow at the highest CAGR during the forecast period.
Key players operating in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).
Get The PDF Brochure For This Report@
http://www.marketsandmarkets.com/pdfdownload.asp?id=548

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441